BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16076491)

  • 1. Lymphoma cells protected from apoptosis by dysregulated bcl-2 continue to bind annexin V in response to B-cell receptor engagement: a cautionary tale.
    Holder MJ; Barnes NM; Gregory CD; Gordon J
    Leuk Res; 2006 Jan; 30(1):77-80. PubMed ID: 16076491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells.
    Heckman CA; Mehew JW; Boxer LM
    Oncogene; 2002 May; 21(24):3898-908. PubMed ID: 12032828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death.
    Hammill AK; Uhr JW; Scheuermann RH
    Exp Cell Res; 1999 Aug; 251(1):16-21. PubMed ID: 10438567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
    Duan H; Heckman CA; Boxer LM
    Oncogene; 2007 Apr; 26(18):2635-41. PubMed ID: 17043638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactadherin binding and phosphatidylserine expression on cell surface-comparison with annexin A5.
    Dasgupta SK; Guchhait P; Thiagarajan P
    Transl Res; 2006 Jul; 148(1):19-25. PubMed ID: 16887494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells.
    Heckman CA; Wheeler MA; Boxer LM
    Oncogene; 2003 Sep; 22(39):7891-9. PubMed ID: 12970736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression.
    Heckman CA; Duan H; Garcia PB; Boxer LM
    Oncogene; 2006 Feb; 25(6):888-98. PubMed ID: 16186795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
    Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of annexin V to bilayers with various phospholipid compositions using glass beads in a flow cytometer.
    Stuart MC; Reutelingsperger CP; Frederik PM
    Cytometry; 1998 Dec; 33(4):414-9. PubMed ID: 9845435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DNA of annexin V-binding apoptotic cells is highly fragmented.
    Bacsó Z; Everson RB; Eliason JF
    Cancer Res; 2000 Aug; 60(16):4623-8. PubMed ID: 10969816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of apoptosis in human B-lymphoma cells by CD40-ligand and Bcl-2: relationship to the cell-cycle and role of the retinoblastoma protein.
    Wang H; Grand RJ; Milner AE; Armitage RJ; Gordon J; Gregory CD
    Oncogene; 1996 Jul; 13(2):373-9. PubMed ID: 8710376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology, pathogenesis and molecular genetics of follicular NHL.
    Leich E; Ott G; Rosenwald A
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):95-109. PubMed ID: 21658611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bcl-2 oncogene and apoptosis.
    Hockenbery DM
    Semin Immunol; 1992 Dec; 4(6):413-20. PubMed ID: 1286168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
    Capaccioli S; Quattrone A; Schiavone N; Calastretti A; Copreni E; Bevilacqua A; Canti G; Gong L; Morelli S; Nicolin A
    Oncogene; 1996 Jul; 13(1):105-15. PubMed ID: 8700536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD10 antigen expression correlates with the t(14;18)(q32;q21) major breakpoint region in diffuse large B-cell lymphoma.
    Fang JM; Finn WG; Hussong JW; Goolsby CL; Cubbon AR; Variakojis D
    Mod Pathol; 1999 Mar; 12(3):295-300. PubMed ID: 10102615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta-mediated apoptosis in the Ramos B-lymphoma cell line is accompanied by caspase activation and Bcl-XL downregulation.
    Saltzman A; Munro R; Searfoss G; Franks C; Jaye M; Ivashchenko Y
    Exp Cell Res; 1998 Jul; 242(1):244-54. PubMed ID: 9665822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
    Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
    Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD20- and B-cell receptor-mediated apoptosis: evidence for shared intracellular signaling pathways.
    Mathas S; Rickers A; Bommert K; Dörken B; Mapara MY
    Cancer Res; 2000 Dec; 60(24):7170-6. PubMed ID: 11156427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioblastoma cells deficient in DNA-dependent protein kinase are resistant to cell death.
    Chen GG; Sin FL; Leung BC; Ng HK; Poon WS
    J Cell Physiol; 2005 Apr; 203(1):127-32. PubMed ID: 15493013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Putative tumor suppressor Lats2 induces apoptosis through downregulation of Bcl-2 and Bcl-x(L).
    Ke H; Pei J; Ni Z; Xia H; Qi H; Woods T; Kelekar A; Tao W
    Exp Cell Res; 2004 Aug; 298(2):329-38. PubMed ID: 15265683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.